Commonly asked questions: Thrombolytic therapy in the management of acute stroke

Expert Review of Neurotherapeutics

Volumn 13, Issue 2, 2013, Pages 157-165

  Block, H Steven ^a   Biller, Jose ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Acute ischemic stroke; Brain tumor; Cardiac catheterization; Cardiac tamponade; Cerebral microhemorrhages; Cervical artery dissection; Ischemic penumbra; Leukoaraiosis; Multimodal imaging; Myocardial infarction; Occult intracranial aneurysm; T PA

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRINOLYTIC AGENT; THROMBIN INHIBITOR; UROKINASE;

ACUTE HEART INFARCTION; ARTERY DISSECTION; BASAL GANGLION; BASILAR ARTERY OBSTRUCTION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC THERAPY; GANGLION; GLIOBLASTOMA; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RUPTURE; HEART TAMPONADE; HEMATOMA; HEMOPERICARDIUM; HUMAN; INTRACRANIAL ANEURYSM; INTRACRANIAL TUMOR; LEUKOARAIOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MENINGIOMA; META ANALYSIS (TOPIC); NEUROIMAGING; PATIENT SAFETY; PERFUSION WEIGHTED IMAGING; PHASE 2 CLINICAL TRIAL (TOPIC); QUADRIPLEGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REVASCULARIZATION; REVIEW; STENT; STEREOTACTIC BIOPSY;

DISEASE MANAGEMENT; HUMANS; STROKE; THROMBOLYTIC THERAPY;

EID: 84873170860     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.163     Document Type: Review

References (74)

1. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 8(7), 635-642 (2009).
2. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25(7), 1342-1347 (1994). (Pubitemid 24198577)
3. Connolly ES Jr, Rabinstein AA, Carhuapoma JR et al.; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 43(6), 1711-1737 (2012).
4. Tarlov N, Norbash AM, Nguyen TN. The safety of anti-coagulation of patients withintracranial aneurysms. J. Neurointerv Surg. (2012).
5. Edwards NJ, Kamel H, Josephson SA. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke 43(2), 412-416 (2012).
6. Mittal MK, Seet RC, Zhang Y, Brown RD Jr, Rabinstein AA. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J. Stroke Cerebrovasc. Dis. (2012).
7. Kim JT, Park MS, Yoon W, Cho KH. Detection and significance of incidental unruptured cerebral aneurysms in patients undergoing intravenous thrombolysis for acute ischemic stroke. J. Neuroimaging 22(2), 197-200 (2012).
8. Sheth KN, Shah N, Morovati T, Hermann LD, Cronin CA. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Neurocritical Care 17(2), 199-203 (2012).
9. Loumiotis I, Wagenbach RN, Brown RD, Lanzino G. Small (<10 mm) incidentally found intracranial aneurysms, part 1: reasons for detection, demographics, location and risk factors in 212 consecutive patients. Neurosurgic Focus. 31(6), E3 (2011).
10. Lagares A, Gómez PA, Lobato RD, Alén JF, Campollo J, Benito-León J. Cerebral aneurysm rupture after r-tPA thrombolysis for acute myocardial infarction. Surg. Neurol. 52(6), 623-626 (1999). (Pubitemid 30045625)
11. Rammos SK, Neils DM, Fraser K, Klopfenstein JD. Anterior communicating artery aneurysm rupture after intravenous thrombolysis for acute middle cerebral artery thromboembolism: case report. Neurosurgery 70(6), E1603-E1607; discussion E1607 (2012).
12. Wiebers DO, Whisnant JP, Huston J 3rd et al.; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362(9378), 103-110 (2003). (Pubitemid 36831019)
13. Lu HT, Tan HQ, Gu BX, Wu-Wang, Li MH. Risk factors for multiple intracranial aneurysms rupture: a retrospective study. Clin. Neurol. Neurosurg. doi:10.1016/j. clineuro.2012.08.011 (2012) (Epub ahead of print).
14. Wong GK, Teoh J, Chan EK, Ng SC, Poon WS. Intracranial aneurysm size responsible for spontaneous subarachnoid haemorrhage. Br. J. Neurosurg. (2012).
15. Lazzaro MA, Ouyang B, Chen M. The role of Circle of Willis anomalies in cerebral aneurysm rupture. J. Neurointerv. Surg. 4(1), 22-26 (2012).
16. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann. Intern. Med. 143(11), 785-792 (2005).
17. Figueras J, Barrabés JA, Serra V et al. Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction. Circulation 122(19), 1902-1909 (2010).
18. Becker RC, Gore JM, Lambrew C et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J. Am. Coll. Cardiol. 27(6), 1321-1326 (1996). (Pubitemid 26151666)
19. Becker RC, Hochman JS, Cannon CP et al. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J. Am. Coll. Cardiol. 33(2), 479-487 (1999). (Pubitemid 29234211)
20. Patel MR, Meine TJ, Lindblad L et al. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am. Heart J. 151(2), 316-322 (2006). (Pubitemid 43144731)
21. Fang L, Gao XM, Moore XL et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J. Mol. Cell. Cardiol. 43(5), 535-544 (2007). (Pubitemid 47615041)
22. Peuhkurinen KJ, Risteli L, Melkko JT, Linnaluoto M, Jounela A, Risteli J. Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulation 83(6), 1969-1975 (1991).
23. Van de Graaff E, Dutta M, Das P et al. Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction. Stroke 37, 2546-2551 (2006). (Pubitemid 44454677)
24. Loh E, Sutton MS, Wun CC et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N. Engl. J. Med. 336(4), 251-257 (1997). (Pubitemid 27044626)
25. Adams HP Jr, del Zoppo G, Alberts MJ et al.; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38(5), 1655-1711 (2007).
26. De Silva DA, Manzano JJ, Chang HM, Wong MC. Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology 76(21), 1838-1840 (2011).
27. Lin R, Aleu A, Jankowitz B et al. Endovascular revascularization of chronic symptomatic vertebrobasilar occlusion. J. Neuroimaging 22(1), 74-79 (2012).
28. Ottomeyer C, Zeller J, Fesl G et al. Multimodal recanalization therapy in acute basilar artery occlusion: long-term functional outcome and quality of life. Stroke 43(8), 2130-2135 (2012).
29. Schonewille WJ, Wijman CA, Michel P et al.; BASICS study group. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 8(8), 724-730 (2009).
30. Arnold M, Fischer U, Compter A et al.; BASICS Study Group. Acute basilar artery occlusion in the Basilar Artery International Cooperation Study: does gender matter? Stroke 41(11), 2693-2696 (2010).
31. Hlatky MA, Greenland P, Arnett DK et al.; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119(17), 2408-2416 (2009).
32. Demchuk AM, Khan F, Hill MD et al.; NINDS rt-PA Stroke Study Group. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PAStroke Study. Cerebrovasc. Dis. 26(2), 120-125 (2008).
33. Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55(7), 947-951 (2000).
34. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 52(5), 991-994 (1999). (Pubitemid 29161609)
35. Greenberg SM, Vernooij MW, Cordonnier C et al.; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 8(2), 165-174 (2009).
36. Kidwell CS, Saver JL, Villablanca JP et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33(1), 95-98 (2002). (Pubitemid 34052192)
37. Fiehler J, Albers GW, Boulanger JM et al.; MR STROKE Group. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL): pooled analysis of T2-weighted magnetic resonance imaging data from 570 patients. Stroke 38(10), 2738-2744 (2007). (Pubitemid 47494012)
38. Sloan MA, Price TR, Petito CK et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45(4), 649-658 (1995).
39. Wijdicks EF, Jack CR Jr. Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 24(4), 554-557 (1993). (Pubitemid 23100742)
40. Pendlebury WW, Iole ED, Tracy RP, Dill BA. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann. Neurol. 29(2), 210-213 (1991).
41. Kase CS, O'Neal AM, Fisher M, Girgis GN, Ordia JI. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann. Intern. Med. 112(1), 17-21 (1990). (Pubitemid 20026364)
42. Ramsay DA, Penswick JL, Robertson DM. Fatal streptokinase-induced intracerebral haemorrhage in cerebral amyloid angiopathy. Can. J. Neurol. Sci. 17(3), 336-341 (1990). (Pubitemid 20254763)
43. Leblanc R, Haddad G, Robitaille Y. Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery 31(3), 586-590 (1992).
44. Winkler DT, Biedermann L, Tolnay M et al. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann. Neurol. 51(6), 790-793 (2002). (Pubitemid 34568863)
45. Barreto AD, Martin-Schild S, Hallevi H et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke 40(3), 827-832 (2009).
46. Adams HP Jr, Leira EC, Torner JC et al.; AbESTT-II Investigators. Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke 39(12), 3277-3282 (2008).
47. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12(6), 723-725 (1981). • Initial description of the concept of ischemic penumbra. (Pubitemid 12227362)
48. Barber PA, Darby DG, Desmond PM et al. Prediction of stroke outcome with echoplanar perfusion- and diffusionweighted MRI. Neurology 51(2), 418-426 (1998). (Pubitemid 28406316)
49. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 353(9169), 2036-2037 (1999). (Pubitemid 29271751)
50. Wintermark M, Rowley HA, Lev MH. Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro CT. Radiology 251(3), 619-626 (2009).
51. Köhrmann M, Schellinger PD. Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imaging. Radiology 251(3), 627-633 (2009).
52. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 41(9), 1996-2000 (2010).
53. Wintermark M, Reichhart M, Cuisenaire O et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusionweighted magnetic resonance imaging in acute stroke patients. Stroke 33(8), 2025-2031 (2002). (Pubitemid 34840062)
54. Wintermark M, Flanders AE, Velthuis B et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 37(4), 979-985 (2006).
55. Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann. Neurol. 61(6), 533-543 (2007). (Pubitemid 47068135)
56. Dankbaar JW, Hom J, Schneider T et al. Age and anatomy-related values of blood- brain barrier permeability measured by perfusion-CT in non-stroke patients. J. Neuroradiol. 36, 219-217 (2009).
57. Leiva-Salinas C, Provenzale JM, Wintermark M. Responses to the 10 most frequently asked questions about perfusion CT. AJR. Am. J. Roentgenol. 196(1), 53-60 (2011).
58. Provenzale JM, Wintermark M. Optimization of perfusion imaging for acute cerebral ischemia: review of recent clinical trials and recommendations for future studies. AJR. Am. J. Roentgenol. 191(4), 1263-1270 (2008).
59. Mishra NK, Albers GW, Davis SM et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 41(1), e25-e33 (2010).
60. Lansberg MG, Straka M, Kemp S et al.; DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 11(10), 860-867 (2012).
61. Thomalla G, Cheng B, Ebinger M et al.; STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 10(11), 978-986 (2011).
62. Cheng B, Brinkmann M, Forkert ND et al. Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J. Cereb. Blood Flow Metab. doi:10.1038/jcbfm.2012.129 (2012) (Epub ahead of print).
63. Zinkstok SM, Vergouwen MD, Engelter ST et al. Safety and functional outcome of thrombolysis in dissection-related ischemicstroke: a meta-analysis of individual patient data. Stroke 42(9), 2515-2520 (2011).
64. Quershi AI, Chaudry SA, Hassan AE et al. Thrombolytic treatment of patients with acute ischemic stroke related to underlying arterial dissection in the United States. Arch Neurol. 68, 1536-1542 (2011).
65. Arnold M, Nedeltchev K, Sturzenegger M et al. Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. Arch. Neurol. 59(4), 549-553 (2002). (Pubitemid 34289958)
66. Cerrato P, Berardino M, Bottacchi E et al. Vertebral artery dissection complicated by basilar artery occlusion successfully treated with intra-arterial thrombolysis: three case reports. Neurol. Sci. 29(1), 51-55 (2008).
67. Sheikh SI, Singhal AB. Extension of 'roller coaster dissection' after tissue plasminogen activator. AJNR. Am. J. Neuroradiol. 31(1), E4 (2010).
68. Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Report. Med. 2011, 503758 (2011).
69. Hsieh HC, Chen CH. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Clin. Neurol. Neurosurg. 111(6), 562-563 (2009).
70. Rubinshtein R, Jaffe R, Flugelman MY, Karkabi B, Lewis BS. Thrombolysis in patients with a brain tumour. Heart 90(12), 1476 (2004). (Pubitemid 39626330)
71. Jaffe R, Reichman JM, Weiss AT, Zahger D. Thrombolysis in the presence of an intracranial meningioma. Chest 111(1), 258 (1997).
72. Grimm SA, DeAngelis LM. Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiforme. Neurology 69(9), 936 (2007). (Pubitemid 47329596)
73. Garcia AM, Egido JA, Garcia ME, Simal P. Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report. BMJ Case Rep. doi:10.1136/bcr.06.2008.0268 (2009).
74. Block HS, Morales-Vidal S, Hornik A, Biller J, Levine SR. Cardiac catheterization: neurological complications. In: MedLink Neurology. Gilman S (Ed.). MedLink Corporation, San Diego, CA, USA. www.medlink.com (Accessed 14 March 2012)